Revolution Medicines RVMD
NASDAQ RVMD
$199.86 +9.12 (+4.78%)
At close: Sep 24, 2026 · 4:00 PM EDT

Revolution Medicines (RVMD) Current Assets (2019 - 2026)

Revolution Medicines (RVMD) posted Current Assets of $4.0 billion for Q2 2026, up 104.7% on a QoQ basis from $2.0 billion in Q1 2026, and up 85.09% year-over-year from $2.2 billion in Q2 2025.

Analysis

Revolution Medicines (RVMD) Current Assets (2019 - 2026) Analysis & Trends

Revolution Medicines has reported Current Assets for 8 years, with the latest figure at $4.0 billion in Q2 2026.

  • On a quarterly basis, Current Assets rose 85.09% year-over-year to $4.0 billion in Q2 2026; TTM through Jun 2026 was $4.0 billion, a 85.09% increase from a year earlier, with the FY2025 full-year figure at $2.1 billion, down 10.85% from the prior year.
  • Current Assets was $4.0 billion for Q2 2026 at Revolution Medicines, up from $2.0 billion in the prior quarter.
  • The five-year high for Current Assets was $4.0 billion in Q2 2026, with the low at $483.0 million in Q2 2022.
  • Average Current Assets over 5 years is $1.6 billion, with a median of $1.7 billion recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: Current Assets fell 26.92% in 2022, then surged 184.66% in 2023.
  • Over 5 years, Current Assets stood at $660.2 million in 2022, then soared by 184.66% to $1.9 billion in 2023, then climbed by 23.86% to $2.3 billion in 2024, then fell by 10.85% to $2.1 billion in 2025, then soared by 94.13% to $4.0 billion in 2026.
  • The last three Current Assets figures came in at $4.0 billion (Q2 2026), $2.0 billion (Q1 2026), and $2.1 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 59.77 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 33.67 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 27.97 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 13.95 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 12.54 Bn
10 Revolution Medicines 40.86 Bn 40.86 Bn - 4.03 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.03 Bn
Mar 31, 2026 1.97 Bn
Dec 31, 2025 2.08 Bn
Sep 30, 2025 1.98 Bn
Jun 30, 2025 2.18 Bn
Mar 31, 2025 2.13 Bn
Dec 31, 2024 2.33 Bn
Sep 30, 2024 1.58 Bn
Jun 30, 2024 1.62 Bn
Mar 31, 2024 1.73 Bn
Dec 31, 2023 1.88 Bn
Sep 30, 2023 824.47 Mn
Jun 30, 2023 922.09 Mn
Mar 31, 2023 922.75 Mn
Dec 31, 2022 660.19 Mn
Sep 30, 2022 675.11 Mn
Jun 30, 2022 483.05 Mn
Mar 31, 2022 534.34 Mn
Dec 31, 2021 589.77 Mn
Sep 30, 2021 623.54 Mn
API Access

Revolution Medicines Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=RVMD&period=max&api_key=YOUR_API_KEY